Higher-throughput screening with human cytochromes P450.

Area of Science:

• Pharmacology
• Drug Metabolism
• Preclinical Studies

Background:

• Cytochrome P450 enzymes play a crucial role in drug metabolism.
• Accurate and efficient measurement of drug metabolism is vital in preclinical drug development.
• Drug-drug interactions mediated by cytochrome P450 enzymes can lead to adverse effects.

Purpose of the Study:

• To review recent innovations for increasing throughput in cytochrome P450 metabolism assays.
• To highlight methods for reducing sample numbers and improving efficiency in drug candidate screening.
• To discuss advancements in identifying potential drug-drug interactions.

Main Methods:

• Simultaneous measurement of multiple analytes in a single High-Performance Liquid Chromatography (HPLC) injection.
• Development and application of fluorometric assays for screening cytochrome P450 inhibition.
• Review of established and novel techniques in preclinical drug metabolism studies.

Main Results:

• Simultaneous analysis significantly reduces sample requirements for HPLC-based assays.
• Fluorometric assays provide a high-throughput method for screening drug-drug interaction mechanisms.
• Both innovations lead to substantial increases in experimental throughput.
• Resource requirements for routine preclinical studies are decreased.

Conclusions:

• Technological advancements are enhancing the efficiency of drug metabolism and interaction studies.
• These innovations streamline preclinical drug development processes.
• Reduced resource utilization enables faster screening of drug candidates.